ORINY

$43.02+$0.93 (+2.20%)prev close

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

52-week range

$30.89 – $43.22

98% from low

Exchange

OTC Link

ADRC

Change+$22.12

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$2.2B	+30.2%	$2.30	$2.26–$2.35	18.7×	1
2027	$2.1B	-7.4%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Intrinsic value

$27.56

Price

$43.02

Implied downside

-36%

Symbol	Price	Today	Mkt cap	P/E
ORINYOrion Oyj	$43.02	+0.00%	$24.2B	—
ALPMFAstellas Pharma Inc.	$13.45	-16.20%	$24.1B	—
ALPMYAstellas Pharma Inc.	$14.72	+1.31%	$26.4B	—
CLPBYColoplast A/S	$6.68	-0.45%	$15.1B	—
GIKLYGrifols, S.A.	$5.10	+0.00%	$13.4B	—
OTSKFOtsuka Holdings Co., Ltd.	$77.53	+0.00%	$40.7B	—

Source: Financial Modeling Prep · peers by sector/industry

No one on the platform currently holds ORINY.

Institutions holding (13F)

No tracked institution reports a position in ORINY as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

TTM yield · 4.40% ($1.89/share)

No one on the platform has traded ORINY yet.